preliminary study of the efficacy of 5ALA on prostate cancer

preliminary study of the efficacy of 5ALA on prostate cancer - preliminary study of the efficacy of 5ALA on prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002251

Enrollment

Registered

2009-08-01

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

5ALA oral intake

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: photo-sensitive patients

Design outcomes

Primary

Measure	Time frame
the existence or nonexistence of fluorescence in tumor	—

Countries

Japan

Contacts

Public ContactIsao KURODA

Saitama Medical University,International Medical Center Uro-oncology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026